Karl-Johan Öhman

Rubin Medical AB markets and trades medical equipment. Its products include: t:slim X2™ Insulinpump, Eversense XL, infusion sets, reservoirs, carriers, accessories, and other insulin pumps. The company is headquartered in Limhamn, Sweden.

Essentys AB is an innovative biotech company developing therapeutics for the treatment and prevention of diseases in the elderly. The Company is currently focused on the development of its lead product ES 1 in osteoporosis, in which proof of concept has been obtained in clinical phase II studies. ES 1 constitutes a completely new approach to the treatment and prevention of osteoporosis. The data suggest that ES 1 has an anabolic effect on collagen (the main constituent of the organic structure of bone), potentially resulting in stronger bone. ES 1 is expected to have an excellent safety profile thereby making long-term use possible. Essentys envisages the use of ES 1 in a broad target group, either as a stand-alone therapy or in combination with other forms of treatment. The clinical results show efficacy of ES 1 in osteoporosis through a significant increase in BMD (Bone Mineral Density) and a positive effect on bone turnover markers. The data have been presented at the American Society of Bone and Mineral Research (ASBMR). The study was conducted in compliance with Good Clinical Practice (cGCP) and Good Manufacturing Practice (cGMP). Essentys is seeking a licensing partner for the further development of ES 1 in osteoporosis.